InvestSMART

Genetic Signatures Limited (ASX: GSS) - Announcements

Current share price for GSS : $0.080 0.007 (8.05%)+

ASX company news and announcements for Genetic Signatures Limited (GSS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Signatures Limited (GSS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Signatures Limited (GSS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Signatures Limited (GSS)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$18 2017 AGM Presentation 28 Nov 2017 10:13AM $0.290 $0.080 fallen by 72.41%
$18 Clarification of Change in Substantial Shareholding 24 Nov 2017 12:54PM $0.290 $0.080 fallen by 72.41%
$18 Change in substantial holding 24 Nov 2017 8:20AM $0.290 $0.080 fallen by 72.41%
$18 Appendix 4C - quarterly 30 Oct 2017 9:11AM $0.380 $0.080 fallen by 78.95%
$18 Notice of Annual General Meeting/Proxy Form 27 Oct 2017 12:00PM $0.380 $0.080 fallen by 78.95%
$18 Annual Report to shareholders 27 Oct 2017 11:58AM $0.380 $0.080 fallen by 78.95%
$18 Change of Director's Interest Notice 19 Sep 2017 12:09PM $0.400 $0.080 fallen by 80%
$18 Notification of 2017 AGM date 15 Sep 2017 5:04PM $0.400 $0.080 fallen by 80%
$18 Appendix 4G and 2017 Corporate Governance Statement 30 Aug 2017 10:08AM $0.420 $0.080 fallen by 80.95%
$18 Appendix 4E and 2017 Financial Report 30 Aug 2017 9:56AM $0.420 $0.080 fallen by 80.95%
$18 Appendix 3B 2 Aug 2017 1:06PM $0.450 $0.080 fallen by 82.22%
$18 Investor Presentation 26 Jul 2017 8:25AM $0.430 $0.080 fallen by 81.40%
$18 Appendix 4C - quarterly 25 Jul 2017 8:28AM $0.430 $0.080 fallen by 81.40%
$18 Appendix 3B 11 Jul 2017 8:25AM $0.430 $0.080 fallen by 81.40%
$18 Change of Director's Interest Notice 30 Jun 2017 8:26AM $0.400 $0.080 fallen by 80%
$18 Regulatory and Patent approval 20 Jun 2017 9:22AM $0.400 $0.080 fallen by 80%
$18 Appendix 4C - quarterly 28 Apr 2017 9:39AM $0.430 $0.080 fallen by 81.40%
$18 Results of Flavivirus Clinical Trial 24 Apr 2017 9:16AM $0.400 $0.080 fallen by 80%
$18 Ceasing to be a substantial holder 31 Mar 2017 2:11PM $0.430 $0.080 fallen by 81.40%
$18 GSS Launches Sexually Transmitted Infection (STI) Kit 31 Mar 2017 8:26AM $0.460 $0.080 fallen by 82.61%
$18 End of escrow period 15 Mar 2017 11:10AM $0.370 $0.080 fallen by 78.38%
$18 Change of Director's Interest Notice 10 Mar 2017 5:36PM $0.385 $0.080 fallen by 79.22%
$18 Appendix 4D - Half Yearly Report and Accounts 27 Feb 2017 9:35AM $0.395 $0.080 fallen by 79.75%
$18 Appendix 3B 23 Feb 2017 5:54PM $0.405 $0.080 fallen by 80.25%
$18 Appendix 4C - quarterly 31 Jan 2017 9:35AM $0.415 $0.080 fallen by 80.72%

401 - 425 of 514 results

Page 17 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.